EH
Ed Hurwitz
OtherActiveManaging Director at MPM Capital
Atherton, United StatesFounded 2016
64
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Ed Hurwitz.
Investment Thesis & Strategy
MPM Capital invests in various stages of biotech and pharmaceutical companies, focusing on innovative therapeutics and platform technologies.
Portfolio Companies
Selected investments from their portfolio of 64 companies
S
Sideris Pharmaceuticals
Other · , 0
I
Iconic Therapeutics
Other · , 0
D
Dyne Therapeutics
Other · , 0
B
Blade Therapeutics
Other · , 0
T
Theraclone Sciences
Other · , 0
V
Vascular Pharmaceuticals
Other · , 0
F
Foldrx Pharmaceuticals
Other · , 0
C
Celladon
Other · , 0
R
Raze Therapeutics
Other · , 0
C
Conatus Pharmaceuticals
Other · , 0
T
Twentyeight-Seven Therapeutics
Other · , 0
A
Amphivena Therapeutics
Other · , 0
Frequently Asked Questions
Ed Hurwitz focuses on Seed stage investments.